Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Clinical Chemistry
|
July 27, 2002
Practice guidelines for tumor marker use in the clinic
Catharine Sturgeon
Expert Review of Proteomics
|
July 27, 2010
Perspectives in Clinical Proteomics Conference: translating clinical proteomics into clinical practice
Catharine Sturgeon
Annals of Clinical Biochemistry
|
July 11, 2006
Expecting the unexpected--the continued need for vigilance in tumour marker assays
Catharine Sturgeon
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|
August 20, 2016
Standardization of tumor markers - priorities identified through external quality assessment
Catharine Sturgeon
Methods in Molecular Biology (Clifton, N.J.)
|
September 3, 2013
External quality assessment schemes for immunoassays
Catharine Sturgeon
Annals of Clinical Biochemistry
|
November 9, 2010
Development and validation of new biomarkers: major opportunities for health-care scientists
Catharine Sturgeon, Peter Selby
Trends in Endocrinology and Metabolism: TEM
|
September 24, 2014
Pregnancy testing with hCG--future prospects
Peter Berger, Catharine Sturgeon
Proteomics. Clinical Applications
|
December 8, 2010
Taking a new biomarker into routine use--a perspective from the routine clinical biochemistry laboratory
Catharine Sturgeon, Robert Hill, Glen L Hortin, et al.
Clinical Chemistry
|
October 30, 2004
Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin
Adrian Bristow, Peter Berger, Jean-Michel Bidart, et al.
Clinical Chemistry and Laboratory Medicine
|
February 5, 2021
Recommendations for validation testing of home pregnancy tests (HPTs) in Europe
Catharine Sturgeon, Stephen A Butler, Fiona Gould, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Clinical Chemistry
|
July 27, 2002
Practice guidelines for tumor marker use in the clinic
Catharine Sturgeon
Expert Review of Proteomics
|
July 27, 2010
Perspectives in Clinical Proteomics Conference: translating clinical proteomics into clinical practice
Catharine Sturgeon
Annals of Clinical Biochemistry
|
July 11, 2006
Expecting the unexpected--the continued need for vigilance in tumour marker assays
Catharine Sturgeon
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|
August 20, 2016
Standardization of tumor markers - priorities identified through external quality assessment
Catharine Sturgeon
Methods in Molecular Biology (Clifton, N.J.)
|
September 3, 2013
External quality assessment schemes for immunoassays
Catharine Sturgeon
Annals of Clinical Biochemistry
|
November 9, 2010
Development and validation of new biomarkers: major opportunities for health-care scientists
Catharine Sturgeon, Peter Selby
Trends in Endocrinology and Metabolism: TEM
|
September 24, 2014
Pregnancy testing with hCG--future prospects
Peter Berger, Catharine Sturgeon
Proteomics. Clinical Applications
|
December 8, 2010
Taking a new biomarker into routine use--a perspective from the routine clinical biochemistry laboratory
Catharine Sturgeon, Robert Hill, Glen L Hortin, et al.
Clinical Chemistry
|
October 30, 2004
Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin
Adrian Bristow, Peter Berger, Jean-Michel Bidart, et al.
Clinical Chemistry and Laboratory Medicine
|
February 5, 2021
Recommendations for validation testing of home pregnancy tests (HPTs) in Europe
Catharine Sturgeon, Stephen A Butler, Fiona Gould, et al.
Page
of 2